OR WAIT 15 SECS
Clearstone Central Laboratories
announced that it has entered into a partnership with
Mitsubishi Chemical Medience Corporation
(Mitsubishi). This preferred provider relationship provides clients of both companies with access to CAP-accredited laboratories for safety and specialty testing services throughout the Asia-Pacific region and around the world. The cross-collaboration opens access for Mitsubishi clients not only to Clearstone’s lab in China but to its global laboratory network, and creates a new solution for Clearstone clients to access Mitsubishi’s lab network in Japan.
“We are very pleased to announce the Mitsubishi partnership given the value and opportunities it creates for our clients”, said Clearstone CEO Lewis Cameron. “Mitsubishi is well established in Japan, and this agreement extends their reach and capabilities to other strategic markets, including our renowned laboratory in China. We look forward to aligning our operational and business development activities, as well as providing our clients with access to the Japanese market”.
This announcement follows a collaborative agreement that Clearstone signed with the Esoterix Clinical Trials Services division of LabCorp last year.